InMed Pharmaceuticals Inc. (INM) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 6.89M | 12.06M | 15.06M | 17.53M | 9.13M | 7.87M | 9.88M | 11.88M | 13.66M | 15.65M | 11.23M | 15.01M |
| Cash & Short-Term Investments | 5.2M | 9.6M | 13.01M | 15.09M | 6.66M | 4.92M | 7.58M | 8.99M | 10.31M | 12.64M | 9.13M | 11.81M |
| Cash Only | 5.16M | 9.55M | 13.01M | 15.09M | 6.66M | 4.92M | 7.58M | 8.99M | 10.31M | 12.64M | 9.13M | 11.81M |
| Short-Term Investments | 41.63K | 58.57K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 251.05K | 479.05K | 633.67K | 523.81K | 377.6K | 386.36K | 482.55K | 281.82K | 494.24K | 224.6K | 344.97K |
| Days Sales Outstanding | - | 29.84 | 45.7 | 29.63 | 32.15 | 31.61 | 31.61 | 27.11 | 30.11 | 26.66 | 29.05 | 8.55 |
| Inventory | 0 | 947.9M | 1.24M | 1.31M | 1.16M | 1.59M | 1.66M | 1.7M | 1.62M | 987.28K | 1.53M | 2.14M |
| Days Inventory Outstanding | - | 40.07K | 163.73 | 113.27 | 113.79 | 229.18 | 200.26 | 185.01 | 134.34 | 126.63 | 192.01 | 182.71 |
| Other Current Assets | 1.69M | -945.69M | 327.22K | 497.46K | 781.06K | 984.76K | 260.68K | 712.28K | 1.44M | 1.53M | 349.33K | 718.62K |
| Total Non-Current Assets | 2.25M | 3.3M | 3.57M | 3.7M | 4.09M | 4.36M | 4.32M | 4.29M | 4.47M | 4.57M | 3.55M | 3.68M |
| Property, Plant & Equipment | 642.88K | 764.25M | 1.23M | 1.35M | 1.58M | 1.77M | 1.82M | 1.71M | 1.86M | 1.96M | 832.92K | 958.37K |
| Fixed Asset Turnover | 1.73x | 0.00x | 0.87x | 1.21x | 0.75x | 0.62x | 0.72x | 0.72x | 0.61x | 0.89x | 1.01x | 3.10x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.5M | 1.54B | 2.2M | 2.21M | 2.37M | 2.45M | 2.36M | 2.44M | 2.47M | 2.47M | 2.58M | 2.58M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 104.37K | -2.3B | 139.47K | 136.24K | 142.41K | 143.81K | 135.71K | 136.76K | 135.7K | 132.55K | 137.85K | 138.98K |
| Total Assets | 9.13M | 15.36M | 18.64M | 21.23M | 13.22M | 12.23M | 14.2M | 16.17M | 18.13M | 20.22M | 14.78M | 18.69M |
| Asset Turnover | 53.88x | 0.07x | 0.06x | 0.10x | 0.10x | 0.08x | 0.08x | 0.07x | 0.06x | 0.07x | 0.05x | 0.16x |
| Asset Growth % | -30.89% | 25.63% | 31.21% | 31.28% | -27.1% | -39.53% | -3.94% | -13.48% | -9.01% | -11.05% | -26.05% | 13.5% |
| Total Current Liabilities | 2.21M | 2.03M | 2.17M | 2.51M | 2.62M | 2.58M | 1.95M | 2.7M | 2.07M | 2.23M | 1.81M | 2.65M |
| Accounts Payable | 225.05K | 228.81K | 514.78K | 504.29K | 797.23K | 826.27K | 609.33K | 856.4K | 546.38K | 406.2K | 514.42K | 720.91K |
| Days Payables Outstanding | 151.67 | 31.4 | 65.38 | 59.72 | 67.28 | 101.47 | 87.42 | 78.12 | 49.08 | 46.23 | 64.53 | 79.68 |
| Short-Term Debt | 389.38K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.22M | 1.24M | 382.5K | 668.14K | 661.73K | 484.98K | 321.21K | 667.78K | 278.23K | 597.63K | 378.58K | 739.85K |
| Current Ratio | 3.11x | 5.94x | 6.95x | 6.99x | 3.49x | 3.05x | 5.07x | 4.41x | 6.58x | 7.03x | 6.19x | 5.66x |
| Quick Ratio | 3.11x | -460.69x | 6.37x | 6.47x | 3.04x | 2.44x | 4.22x | 3.78x | 5.80x | 6.58x | 5.35x | 4.86x |
| Cash Conversion Cycle | - | 40.07K | 144.05 | 83.19 | 78.66 | 159.32 | 144.44 | 133.99 | 115.37 | 107.06 | 156.53 | 111.57 |
| Total Non-Current Liabilities | 30.77K | 169.96K | 300.53K | 416.57K | 597.2K | 761.11K | 860.11K | 881.94K | 984.15K | 1.06M | 0 | 21.19K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 30.77K | 169.91K | 300.53K | 416.57K | 597.2K | 761.11K | 860.11K | 881.94K | 984.15K | 1.06M | 0 | 21.19K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 2.24M | 2.2M | 2.47M | 2.92M | 3.22M | 3.34M | 2.81M | 3.58M | 3.06M | 3.29M | 1.81M | 2.67M |
| Total Debt | 420.15K | 730.14K | 892.97K | 1.01M | 1.21M | 1.36M | 1.44M | 1.32M | 1.45M | 1.55M | 396.79K | 518.92K |
| Net Debt | -4.74M | -8.82M | -12.12M | -14.08M | -5.46M | -3.55M | -6.14M | -7.67M | -8.86M | -11.09M | -8.73M | -11.29M |
| Debt / Equity | 0.06x | 0.06x | 0.06x | 0.06x | 0.12x | 0.15x | 0.13x | 0.10x | 0.10x | 0.09x | 0.03x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | -125.46x | - | -6.32x | - | - | - | - | - | - |
| Total Equity | 6.89M | 13.16M | 16.17M | 18.3M | 10M | 8.89M | 11.39M | 12.59M | 15.07M | 16.93M | 12.97M | 16.02M |
| Equity Growth % | -31.08% | 48.02% | 41.89% | 45.38% | -33.64% | -47.49% | -12.16% | -21.39% | -10.06% | -12.11% | -14.04% | 37.01% |
| Book Value per Share | 1.70 | 3328.21 | 4088.46 | 9.14 | 9.12 | 12.58 | 18.37 | 28.23 | 31.35 | 42.46 | 77.95 | 96.24 |
| Total Shareholders' Equity | 6.89M | 13.16M | 16.17M | 18.3M | 10M | 8.89M | 11.39M | 12.59M | 15.07M | 16.93M | 12.97M | 16.02M |
| Common Stock | 92.58M | 126.3M | 128.05M | 124.28M | 124.55M | 121.57M | 114.27M | 113.22M | 109.38M | 105.96M | 105.12M | 102.83M |
| Retained Earnings | -123.96M | -166.02M | -165.92M | -159.73M | -164.41M | -162.98M | -150.3M | -149.18M | -145.39M | -139.73M | -140.75M | -134.33M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 128.57K | 176.41K | 179.32K | 175.17K | 183.1K | 184.89K | 174.48K | 175.83K | 174.47K | 170.42K | 174.11K | 170.32K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |